Want to see IN:OMKARCHEM full AI Analyst Report?
Top Page
Omkar Speciality Chemicals Limited
(OMKARCHEM)
Select Model
Select Model
Rating:42Neutral
Price Target:
₹3.50
▼(-18.60% Downside)
Action:N/A
Date:09/24/26
The score is driven primarily by very weak financial performance (large losses, severe revenue contraction, and recent cash burn), with only a partial offset from FY2026 balance-sheet improvement. Technicals remain soft with the stock below its 200-day average and negative MACD, while valuation provides limited support due to a negative P/E and no dividend yield data.
Positive Factors
FY2026 Balance-Sheet Improvement
The return to positive equity and substantially lower reported debt improves financial flexibility compared with the prior period of negative equity. If maintained, this provides a stronger capital base for stabilisation, although the improvement has not yet translated into operating recovery.
Negative Factors
Extreme Revenue Contraction
The collapse in revenue indicates a severe loss of operating scale and materially weakens the company’s ability to absorb fixed costs. Rebuilding a dependable customer and revenue base would be necessary before profitability, cash generation, or competitive position can become durable.
Read all positive and negative factors
Positive Factors
Negative Factors
FY2026 Balance-Sheet Improvement
The return to positive equity and substantially lower reported debt improves financial flexibility compared with the prior period of negative equity. If maintained, this provides a stronger capital base for stabilisation, although the improvement has not yet translated into operating recovery.
Read all positive factors
Omkar Speciality Chemicals Limited (OMKARCHEM) vs. iShares MSCI India ETF (INDA)
Market Cap
₹74.08M
Dividend Yield3.1%
Average Volume (3M)0.00
Price to Earnings (P/E)―
Beta (1Y)0.34
Revenue GrowthN/A
EPS GrowthN/A
CountryIN
Employees59
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-0.34
Shares Outstanding5,000,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.22
Price to Book (P/B)0.41
Price to Sales (P/S)926.01
P/FCF Ratio-4.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Omkar Speciality Chemicals Limited Business Overview & Revenue Model
Company Description
Omkar Speciality Chemicals Limited (OSCL) is a prominent manufacturer and global supplier of specialized chemicals and intermediates, catering to a wide array of chemical and allied sectors both domestically in India and across international marke...
Omkar Speciality Chemicals Limited Financial Statement Overview
Summary
Income Statement
8
Very Negative
Balance Sheet
18
Very Negative
Cash Flow
22
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 82.00K | 82.00K | 2.24M | 229.82M | 229.82M | 451.25M |
| Gross Profit | -4.43M | -9.09M | -9.07M | 62.82M | 62.82M | 118.89M |
| EBITDA | -3.22M | -8.55M | -3.97M | -47.46M | -47.46M | 122.75M |
| Net Income | -6.93M | -15.89M | -13.04M | -126.05M | -126.05M | 20.14M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 456.49M | 480.38M | 721.72M | 721.72M | 863.63M |
| Cash, Cash Equivalents and Short-Term Investments | 26.48M | 26.48M | 44.52M | 103.46M | 3.33M | 1.67M |
| Total Debt | 0.00 | 31.05M | 3.82B | 2.26B | 2.26B | 2.28B |
| Total Liabilities | -187.25M | 269.24M | 4.05B | 2.43B | 2.43B | 2.45B |
| Stockholders Equity | 187.25M | 187.25M | -3.57B | -1.71B | -1.71B | -1.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -16.68M | 9.06M | 8.92M | 8.92M | -164.30M |
| Operating Cash Flow | 0.00 | -14.66M | 9.06M | 8.92M | 8.92M | -164.12M |
| Investing Cash Flow | 0.00 | -2.89M | 1.11M | 1.75M | 1.75M | 173.49M |
| Financing Cash Flow | 0.00 | -487.00K | 0.00 | -10.36M | -10.36M | -10.80M |
Omkar Speciality Chemicals Limited Technical Analysis
Negative
4.30
Price Trends
3.60
Positive
3.60
Negative
4.27
Negative
Market Momentum
>-0.01
Negative
31.33
Neutral
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:OMKARCHEM, the sentiment is Negative. The current price of 4.3 is above the 20-day moving average (MA) of 3.60, above the 50-day MA of 3.60, and above the 200-day MA of 4.27, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 31.33 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:OMKARCHEM.
Omkar Speciality Chemicals Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹67.54B | 47.88 | ― | 0.23% | 91.44% | 19.67% | |
70 Neutral | ₹7.87B | 28.25 | ― | 2.97% | 17.43% | 10.62% | |
57 Neutral | ₹23.69B | 15.35 | ― | 0.12% | 19.47% | 11.49% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | ₹73.13B | 185.03 | ― | 0.04% | 18.00% | 3.85% | |
50 Neutral | ₹48.94B | 39.15 | ― | 0.17% | 5.47% | 24.88% | |
42 Neutral | ₹74.08M | -4.55 | ― | 3.10% | ― | ― |
* General Sector Average
IN:OMKARCHEM
Omkar Speciality Chemicals Limited
3.60
-2.40
-40.00%
IN:CHEMCON
Chemcon Speciality Chemicals Ltd
218.30
-35.60
-14.02%
IN:FCL
Fineotex Chemical Limited
57.50
32.61
130.98%
IN:LXCHEM
Laxmi Organic Industries Ltd.
177.15
-31.74
-15.20%
IN:NEOGEN
Neogen Chemicals Ltd.
2,449.80
937.18
61.96%
IN:ROSSARI
Rossari Biotech Ltd
417.15
-218.49
-34.37%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.